| 1 |
33164600 | Celecoxib and Afatinib synergistic enhance radiotherapy sensitivity on human non-small cell lung cancer A549 cells. | 2021 |
1 |
| 2 |
32658799 | Juvenile recurrent respiratory papillomatosis treated with combined erlotinib and celecoxib: Initial report. | 2020 Oct |
2 |
| 3 |
33116404 | Novel Molecular Mechanism of Aspirin and Celecoxib Targeting Mammalian Neuraminidase-1 Impedes Epidermal Growth Factor Receptor Signaling Axis and Induces Apoptosis in Pancreatic Cancer Cells. | 2020 |
1 |
| 4 |
30038488 | Radiosensitivity enhancement by combined treatment of nimotuzumab and celecoxib on nasopharyngeal carcinoma cells. | 2018 |
1 |
| 5 |
30038944 | The impact of celecoxib on outcomes in advanced prostate cancer patients undergoing androgen deprivation therapy. | 2018 |
1 |
| 6 |
30066906 | Efficacy of gefitinib‑celecoxib combination therapy in docetaxel‑resistant prostate cancer. | 2018 Oct |
1 |
| 7 |
28282799 | Celecoxib-erlotinib combination treatment enhances radiosensitivity in A549 human lung cancer cell. | 2017 |
1 |
| 8 |
28423516 | The addition of celecoxib improves the antitumor effect of cetuximab in colorectal cancer: role of EGFR-RAS-FOXM1-β- catenin signaling axis. | 2017 Mar 28 |
2 |
| 9 |
28450158 | The ErbB family and androgen receptor signaling are targets of Celecoxib in prostate cancer. | 2017 Aug 1 |
5 |
| 10 |
27508092 | Celecoxib-erlotinib combination delays growth and inhibits angiogenesis in EGFR-mutated lung cancer. | 2016 |
4 |
| 11 |
25595386 | Epidermal growth factor receptor-targeted immunoliposomes for delivery of celecoxib to cancer cells. | 2015 Feb 20 |
7 |
| 12 |
25776499 | The cancer pain related factors affected by celecoxib together with cetuximab in head and neck squamous cell carcinoma. | 2015 Mar |
2 |
| 13 |
25987127 | Celecoxib increases EGF signaling in colon tumor associated fibroblasts, modulating EGFR expression and degradation. | 2015 May 20 |
5 |
| 14 |
26033830 | Randomized phase 2 trial of erlotinib in combination with high-dose celecoxib or placebo in patients with advanced non-small cell lung cancer. | 2015 Sep 15 |
2 |
| 15 |
26107817 | Simultaneous inhibition of EGFR/VEGFR and cyclooxygenase-2 targets stemness-related pathways in colorectal cancer cells. | 2015 |
1 |
| 16 |
26464643 | Relationship between epidermal growth factor receptor (EGFR) mutation and serum cyclooxygenase-2 Level, and the synergistic effect of celecoxib and gefitinib on EGFR expression in non-small cell lung cancer cells. | 2015 |
3 |
| 17 |
24085777 | Chemoprevention of head and neck cancer with celecoxib and erlotinib: results of a phase ib and pharmacokinetic study. | 2014 Mar |
1 |
| 18 |
24528083 | Simultaneous blockage of epidermal growth factor receptor and cyclooxygenase-2 in a human xenotransplanted lung cancer model. | 2014 |
1 |
| 19 |
24591842 | Cyclooxygenase-2 inhibitor is a robust enhancer of anticancer agents against hepatocellular carcinoma multicellular spheroids. | 2014 |
1 |
| 20 |
25198789 | Combined cetuximab and celecoxib treatment exhibits a synergistic anticancer effect on human oral squamous cell carcinoma in vitro and in vivo. | 2014 Jul 16 |
4 |
| 21 |
25328959 | Combined cetuximab and celecoxib treatment exhibits a synergistic anticancer effect on human oral squamous cell carcinoma in vitro and in vivo. | 2014 Oct |
4 |
| 22 |
23010081 | Celecoxib induces proliferation and Amphiregulin production in colon subepithelial myofibroblasts, activating erk1-2 signaling in synergy with EGFR. | 2013 Jan 1 |
3 |
| 23 |
23422093 | Chemoprevention of head and neck cancer by simultaneous blocking of epidermal growth factor receptor and cyclooxygenase-2 signaling pathways: preclinical and clinical studies. | 2013 Mar 1 |
1 |
| 24 |
23483082 | Combined Inhibition of Epidermal Growth Factor Receptor and Cyclooxygenase-2 as a Novel Approach to Enhance Radiotherapy. | 2011 Oct 13 |
3 |
| 25 |
19736197 | Regression of recurrent respiratory papillomatosis with celecoxib and erlotinib combination therapy. | 2009 Sep |
1 |
| 26 |
17996386 | Celecoxib induced tumor cell radiosensitization by inhibiting radiation induced nuclear EGFR transport and DNA-repair: a COX-2 independent mechanism. | 2008 Jan 1 |
5 |
| 27 |
18172786 | Selective COX-2 inhibitor celecoxib combined with EGFR-TKI ZD1839 on non-small cell lung cancer cell lines: in vitro toxicity and mechanism study. | 2008 |
1 |
| 28 |
17409801 | Phase II study of gefitinib, an epidermal growth factor receptor tyrosine kinase inhibitor (EGFR-TKI), and celecoxib, a cyclooxygenase-2 (COX-2) inhibitor, in patients with platinum refractory non-small cell lung cancer (NSCLC). | 2007 Apr |
1 |
| 29 |
17505004 | Enhancement of docetaxel-induced cytotoxicity by blocking epidermal growth factor receptor and cyclooxygenase-2 pathways in squamous cell carcinoma of the head and neck. | 2007 May 15 |
1 |
| 30 |
17948911 | Response to dual blockade of epidermal growth factor receptor (EGFR) and cycloxygenase-2 in nonsmall cell lung cancer may be dependent on the EGFR mutational status of the tumor. | 2007 Dec 15 |
2 |
| 31 |
16373709 | Simultaneous targeting of the epidermal growth factor receptor and cyclooxygenase-2 pathways for pancreatic cancer therapy. | 2005 Dec |
2 |
| 32 |
15355926 | Simultaneously targeting epidermal growth factor receptor tyrosine kinase and cyclooxygenase-2, an efficient approach to inhibition of squamous cell carcinoma of the head and neck. | 2004 Sep 1 |
2 |